Chromosomal microarray analysis (CMA) has emerged as a powerful new tool to identify genomic abnormalities associated with a wide range of developmental disabilities including congenital malformations, cognitive impairment, and behavioral abnormalities. CMA includes array comparative genomic hybridization (CGH) and single nucleotide polymorphism…

The research on epilepsy, a neuropsychiatric disorder characterized by seizures, psychopathology, cognitive, and linguistic problems among children in the age group of 0 to 18 years is reported. Early identification of children with epilepsy (CWE) and the development of multidisciplinary management strategies would advance relevant clinical…

Background: The aim in treating epilepsy is to minimise or control seizures with full respect of quality-of-life issues, especially of cognitive functions. Optimal treatment first demands a correct recognition of the major type of seizures, followed by a correct diagnosis of the type of epilepsy or of the specific syndrome. Methods: Review of data…